Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | MMP2 | P08253 | 2/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | COMT | P21964 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | METAP2 | P50579 | 1/20 | 0.55 |
| ▸ | METAP1 | P53582 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | CCR1 | P32246 | 3/20 | 0.53 |
| ▸ | CCR5 | P51681 | 3/20 | 0.53 |
| ▸ | CCR8 | P51685 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL85419 | 0.98 | TSHR (0.56) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL10299988 | 0.89 | TSHR (0.50) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL57699 | 0.88 | IDO1 (0.46) | TDP1LMNAMAPTSMN1; SMN2TP53 | |
| SCHEMBL19831083 | 0.86 | MMP2 (0.47) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL30835076 | 0.86 | MMP2 (0.47) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL30835135 | 0.86 | MMP2 (0.47) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL28609444 | 0.85 | MMP2 (0.46) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL14900783 | 0.84 | LMNA (0.64) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL12853992 | 0.84 | LMNA (0.64) | TSHRMMP2CHRM1COMTADRA1A | |
| SCHEMBL17146643 | 0.83 | KDM4E (0.57) | TSHRMMP2CHRM1COMTADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2232612-B1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | GLOBAL OLED TECHNOLOGY LLC (US) | 2017-02-08 | — | — | EP | disclosed |
| US-8900722-B2 | OLED device employing alkali metal cluster compounds | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-8877356-B2 | OLED device with stabilized yellow light-emitting layer | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-11-04 | — | — | US | disclosed |
| EP-2456617-B1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-07-02 | — | — | EP | disclosed |
| CN-101878554-B | Oled device employing alkali metal cluster compounds | GLOBAL OLED TECHNOLOGY LLC | 2012-07-25 | — | — | CN | disclosed |
| EP-2456617-A1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | Global OLED Technology LLC (US) | 2012-05-30 | — | — | EP | disclosed |
| WO-2011011501-A1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | GLOBAL OLED TECHNOLOGY LLC (US) | 2011-01-27 | — | — | WO | disclosed |
| US-20110018429-A1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | GLOBAL OLED TECHNOLOGY LLC | 2011-01-27 | — | — | US | disclosed |
| CN-101878554-A | Oled device employing alkali metal cluster compounds | EASTMAN KODAK CO | 2010-11-03 | — | — | CN | disclosed |
| EP-2232612-A1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | Global OLED Technology LLC (US) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009073088-A1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | EASTMAN KODAK COMPANY (US) | 2009-06-11 | — | — | WO | disclosed |
| US-20090142618-A1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | GLOBAL OLED TECHNOLOGY LLC | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090142618-A1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | OCIAD2, OCIAD1, OSTC | TSHR 4338/4885MMP2 4104/4885CHRM1 2014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.